Zeria Pharmaceutical Co., Ltd. (4559.T) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Zeria Pharmaceutical Co., Ltd., with annual and quarterly history.
| Metric | 2026 |
|---|---|
| Valuation | |
| P/E Ratio | 11.44x |
| P/B Ratio | 0.89x |
| P/S Ratio | 1.09x |
| Profitability | |
| Gross Margin | 73.1% |
| Operating Margin | 13.9% |
| Net Margin | 9.5% |
| EBITDA Margin | 22.1% |
| Liquidity | |
| Current Ratio | 1.48x |
| Quick Ratio | 1.11x |
| Leverage | |
| Debt/Equity | 0.36x |
YoY = year-over-year change. Source: FMP..